查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813883

人类乳突病毒 (HPV) 检测市场规模、份额和趋势分析报告：按应用、产品、技术、最终用途、地区和细分市场预测，2025 年至 2033 年

Human Papilloma Virus Testing Market Size, Share & Trends Analysis Report By Application (Cervical Cancer Screening, Vaginal Cancer Screening), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

人类乳突病毒（HPV）检测市场摘要

预计 2024 年人类乳突病毒 (HPV) 检测市场价值将达到 17.6 亿美元，到 2033 年将达到 56.7 亿美元，2025 年至 2033 年的复合年增长率为 14.14%。

人类乳突病毒 (HPV) 相关癌症的增加推动了市场的发展，超过 95% 的子宫颈癌是由 HPV 引起的。

为了提高检测灵敏度，澳洲等国家正以HPV DNA检测取代子宫颈抹片。 BD和Hologic等公司推出的自采样套件正在扩大医疗资源匮乏地区的覆盖范围。世界卫生组织的消除策略和非政府组织支持的计画正在推动非洲和亚洲的普及。分子诊断技术的进步、捆绑式女性健康检查以及实验室基础设施的改善，正在使全球检测更加便捷且更具成本效益。子宫颈癌是全球女性第四大常见癌症，也是女性癌症相关死亡的第二大原因。

2020年11月，世界卫生组织（WHO）发布了《终止子宫颈癌全球策略》，设定了2030年的「90-70-90」目标：90%的女孩在15岁前接种疫苗，70%的女性在35岁和45岁时接受筛检，90%的确诊病例得到治疗。到了2022年，只有18%的国家达到建议的70%或更高的筛检率，而全球覆盖率仍维持在20%左右。 HPV导致99.8%的子宫颈癌病例，其中16型和18型基因型就占70%。 19种高危险基因型占HPV相关癌症的90%。由于大多数HPV感染无症状，分子检测对于早期发现至关重要。自 2017 年以来，澳洲和荷兰等国家已从子宫颈抹片检查过渡到初级 HPV DNA 检测，因为它具有更高的灵敏度和更长的筛检间隔。

目录

第一章调查方法与范围

第二章执行摘要

3. 人类乳突病毒 (HPV) 检测市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人类乳突病毒（HPV）检测市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析

第四章 人类乳突病毒（HPV）检测市场：应用评估与趋势分析

  • 应用程式细分仪表板
  • 人类乳突病毒（HPV）检测市场：应用变化分析
  • 2021-2033年全球人类乳突病毒（HPV）检测市场规模及应用趋势分析
  • 子宫颈癌筛检
  • 阴道癌筛检

5. 人类乳突病毒（HPV）检测市场：产品预估及趋势分析

  • 产品细分仪表板
  • 人类乳突病毒（HPV）检测市场：产品差异分析
  • 2021-2033 年全球人类乳突病毒 (HPV) 检测市场规模及趋势分析（按产品）
  • 装置
  • 耗材
  • 服务

6. 人类乳突病毒（HPV）检测市场：技术评估与趋势分析

  • 技术细分仪表板
  • 人类乳突病毒（HPV）检测市场：技术波动分析
  • 2021-2033 年全球人类乳突病毒 (HPV) 检测市场规模及趋势分析（按技术）
  • PCR
  • 免疫诊断
  • 其他的

7. 人类乳突病毒（HPV）检测市场：最终用途预估与趋势分析

  • 最终用途细分仪表板
  • 人类乳突病毒 (HPV) 检测市场：最终用途变异分析
  • 2021-2033 年全球人类乳突病毒 (HPV) 检测市场规模及趋势分析（依最终用途）
  • 医院和诊所
  • 研究所
  • 其他的

8. 人类乳突病毒（HPV）检测市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2021年及2033年区域市占率分析
  • 人类乳突病毒 (HPV) 检测市场（按地区）：关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • Key Company Heat Map Analysis, 2024
  • 公司简介
    • Abbott
    • Biomedical Diagnostics
    • bioMerieux
    • Bio-Rad Laboratories, Inc.
    • Fujirebio
    • Oncolab
    • Hologic, Inc.
    • Qiagen
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
Product Code: GVR-4-68040-549-5

Human Papilloma Virus Testing Market Summary

The human papilloma virus testing market size was estimated at USD 1.76 billion in 2024 and is projected to reach USD 5.67 billion by 2033, growing at a CAGR of 14.14% from 2025 to 2033. The market is fueled by rising HPV-related cancer cases, with human papilloma virus (HPV) causing over 95% of cervical cancers.

Countries like Australia have replaced Pap smears with HPV DNA testing for higher sensitivity. Self-sampling kits, such as those from BD and Hologic, are expanding access in underserved areas. WHO's elimination strategy and NGO-backed programs in Africa and Asia drive adoption. Advances in molecular diagnostics, bundled women's health panels, and improved lab infrastructure make testing more accessible and cost-effective globally. Cervical cancer is the fourth most common cancer among women worldwide and the second leading cause of female cancer-related mortality.

In November 2020, the World Health Organization launched its Global Strategy to Eliminate Cervical Cancer, setting the 90-70-90 targets for 2030-vaccinate 90% of girls by age 15, screen 70% of women at ages 35 and 45, and treat 90% of women with identified disease. This initiative came against alarming statistics: in 2022, only 18% of countries had reached the recommended screening coverage of over 70%, and global coverage still stood at about 20%. HPV is the causative agent in 99.8% of cervical cancer cases, with genotypes 16 and 18 alone responsible for 70% of cases. Nineteen high-risk genotypes account for 90% of all HPV-related cancers. Given the asymptomatic nature of most HPV infections, molecular testing has become essential for early detection. Since 2017, countries such as Australia and the Netherlands have transitioned from Pap smears to primary HPV DNA testing, citing higher sensitivity and longer screening intervals.

Global Human Papilloma Virus Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global human papilloma virus (HPV) testing market report based on application, product, technology, end use, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cervical Cancer Screening
  • Vaginal Cancer Screening
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Consumables
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • PCR
  • Immunodiagnostics
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Product
    • 1.2.3. Technology
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Outlook
    • 2.2.2. Product Outlook
    • 2.2.3. Technology Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Human Papilloma Virus (HPV) Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Human Papilloma Virus (HPV) Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Human Papilloma Virus (HPV) Testing Market: Application Estimates & Trend Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • 4.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Application, 2021 - 2033 (USD Million)
  • 4.4. Cervical Cancer Screening
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Vaginal Cancer Screening
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Human Papilloma Virus (HPV) Testing Market: Product Estimates & Trend Analysis

  • 5.1. Product Segment Dashboard
  • 5.2. Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • 5.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Product, 2021 - 2033 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Consumables
    • 5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Services
    • 5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Human Papilloma Virus (HPV) Testing Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Segment Dashboard
  • 6.2. Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • 6.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Technology, 2021 - 2033 (USD Million)
  • 6.4. PCR
    • 6.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Immunodiagnostics
    • 6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Human Papilloma Virus (HPV) Testing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • 7.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By End Use, 2021 - 2033 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Laboratories
    • 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Human Papilloma Virus (HPV) Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2021 & 2033
  • 8.3. Human Papilloma Virus (HPV) Testing Market by Region: Key Takeaways
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key Country Dynamics
      • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.1.3. Competitive Scenario
      • 8.4.1.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Germany
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.1.3. Competitive Scenario
      • 8.5.1.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Denmark
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Norway
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.8.3. Competitive Scenario
      • 8.5.8.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.1.3. Competitive Scenario
      • 8.6.1.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. South Korea
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.2.3. Competitive Scenario
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.3.3. Competitive Scenario
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.4.3. Competitive Scenario
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.5.3. Competitive Scenario
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/ Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key Company Heat Map Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Abbott
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Biomedical Diagnostics
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. bioMerieux
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Bio-Rad Laboratories, Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Fujirebio
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Oncolab
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Hologic, Inc.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Qiagen
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. F. Hoffmann-La Roche Ltd
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Siemens Healthineers AG
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Human Papilloma Virus (HPV) Testing Market, by Region, 2021 - 2033 (USD Million)
  • Table 4 Global Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 6 Global Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Human Papilloma Virus (HPV) Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 10 North America Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 11 North America Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 14 U.S. Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 15 U.S. Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 18 Canada Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 19 Canada Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Mexico Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 23 Mexico Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Human Papilloma Virus (HPV) Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 27 Europe Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 28 Europe Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30 Germany Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 31 Germany Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 32 Germany Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 33 Germany Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 34 UK Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 35 UK Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 36 UK Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37 UK Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 39 France Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 40 France Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 41 France Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 43 Italy Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 44 Italy Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 47 Spain Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Spain Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 51 Denmark Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Denmark Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 53 Denmark Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 55 Sweden Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Sweden Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 57 Sweden Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58 Norway Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 59 Norway Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 60 Norway Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 61 Norway Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 68 Japan Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 69 Japan Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 70 Japan Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 China Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 72 China Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 73 China Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 74 China Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 India Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 76 India Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 77 India Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 India Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 South Korea Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 80 South Korea Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 81 South Korea Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 82 South Korea Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Australia Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 84 Australia Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 85 Australia Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 86 Australia Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Thailand Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 88 Thailand Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 89 Thailand Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 90 Thailand Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Human Papilloma Virus (HPV) Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 93 Latin America Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 94 Latin America Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 97 Brazil Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 98 Brazil Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 101 Argentina Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 102 Argentina Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 110 South Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 111 South Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 118 UAE Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 119 UAE Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Human Papilloma Virus (HPV) Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Human Papilloma Virus (HPV) Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Human Papilloma Virus (HPV) Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Human Papilloma Virus (HPV) Testing Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Human Papilloma Virus (HPV) Testing Market: Market Outlook
  • Fig. 10 Human Papilloma Virus (HPV) Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Human Papilloma Virus (HPV) Testing Market Driver Impact
  • Fig. 16 Human Papilloma Virus (HPV) Testing Market Restraint Impact
  • Fig. 17 Human Papilloma Virus (HPV) Testing Market Strategic Initiatives Analysis
  • Fig. 18 Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • Fig. 19 Human Papilloma Virus (HPV) Testing Market: Application Outlook and Key Takeaways
  • Fig. 20 Cervical Cancer Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Vaginal Cancer Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • Fig. 23 Human Papilloma Virus (HPV) Testing Market: Product Outlook and Key Takeaways
  • Fig. 24 Instruments Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Consumables Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Services Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • Fig. 28 Human Papilloma Virus (HPV) Testing Market: Technology Outlook and Key Takeaways
  • Fig. 29 PCR Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Immunodiagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • Fig. 33 Human Papilloma Virus (HPV) Testing Market: End Use Outlook and Key Takeaways
  • Fig. 34 Hospitals & Clinics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Laboratories Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Global Human Papilloma Virus (HPV) Testing Market: Regional Movement Analysis
  • Fig. 38 Global Human Papilloma Virus (HPV) Testing Market: Regional Outlook and Key Takeaways
  • Fig. 39 North America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 40 U.S. Market Estimates and Forecasts, 2021 - 2033
  • Fig. 41 Canada Market Estimates and Forecasts, 2021 - 2033
  • Fig. 42 Mexico Market Estimates and Forecasts, 2021 - 2033
  • Fig. 43 Europe Market Estimates and Forecasts, 2021 - 2033
  • Fig. 44 Germany Market Estimates and Forecasts, 2021 - 2033
  • Fig. 45 UK Market Estimates and Forecasts, 2021 - 2033
  • Fig. 46 France Market Estimates and Forecasts, 2021 - 2033
  • Fig. 47 Italy Market Estimates and Forecasts, 2021 - 2033
  • Fig. 48 Spain Market Estimates and Forecasts, 2021 - 2033
  • Fig. 49 Denmark Market Estimates and Forecasts, 2021 - 2033
  • Fig. 50 Sweden Market Estimates and Forecasts, 2021 - 2033
  • Fig. 51 Norway Market Estimates and Forecasts, 2021 - 2033
  • Fig. 52 Asia Pacific Market Estimates and Forecasts, 2021 - 2033
  • Fig. 53 Japan Market Estimates and Forecasts, 2021 - 2033
  • Fig. 54 China Market Estimates and Forecasts, 2021 - 2033
  • Fig. 55 India Market Estimates and Forecasts, 2021 - 2033
  • Fig. 56 South Korea Market Estimates and Forecasts, 2021 - 2033
  • Fig. 57 Australia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 58 Thailand Market Estimates and Forecasts, 2021 - 2033
  • Fig. 59 Latin America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 60 Brazil Market Estimates and Forecasts, 2021 - 2033
  • Fig. 61 Argentina Market Estimates and Forecasts, 2021 - 2033
  • Fig. 62 Middle East & Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 63 South Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 64 Saudi Arabia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 65 UAE Market Estimates and Forecasts, 2021 - 2033
  • Fig. 66 Kuwait Market Estimates and Forecasts, 2021 - 2033